DK0814834T3 - Immunogener, der er blottet for toksicitet, afledt af et retroviralt regulatorprotein, antistoffer, der er rettet mod disse - Google Patents

Immunogener, der er blottet for toksicitet, afledt af et retroviralt regulatorprotein, antistoffer, der er rettet mod disse

Info

Publication number
DK0814834T3
DK0814834T3 DK96906795T DK96906795T DK0814834T3 DK 0814834 T3 DK0814834 T3 DK 0814834T3 DK 96906795 T DK96906795 T DK 96906795T DK 96906795 T DK96906795 T DK 96906795T DK 0814834 T3 DK0814834 T3 DK 0814834T3
Authority
DK
Denmark
Prior art keywords
pct
derived
regulatory protein
immunogens
devoid
Prior art date
Application number
DK96906795T
Other languages
English (en)
Other versions
DK0814834T4 (da
Inventor
Jean-Francois Zagury
Bernard Bizzini
Daniel Zagury
Original Assignee
Neovacs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26231806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0814834(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9502708A external-priority patent/FR2731355B1/fr
Application filed by Neovacs filed Critical Neovacs
Publication of DK0814834T3 publication Critical patent/DK0814834T3/da
Application granted granted Critical
Publication of DK0814834T4 publication Critical patent/DK0814834T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1147—Regulatory proteins, e.g. trans-activator of transcription [TAT], rev or vacuolar protein targeting [VPT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96906795T 1995-03-08 1996-03-07 Immunogener, der er blottet for toksicitet, afledt af et retroviralt regulatorprotein, antistoffer, der er rettet mod disse immunogener, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem DK0814834T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9502708A FR2731355B1 (fr) 1995-03-08 1995-03-08 Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
PCT/FR1996/000357 WO1996027389A1 (fr) 1995-03-08 1996-03-07 Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps, procede de preparation et compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
DK0814834T3 true DK0814834T3 (da) 2000-11-13
DK0814834T4 DK0814834T4 (da) 2009-07-20

Family

ID=26231806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96906795T DK0814834T4 (da) 1995-03-08 1996-03-07 Immunogener, der er blottet for toksicitet, afledt af et retroviralt regulatorprotein, antistoffer, der er rettet mod disse immunogener, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem

Country Status (12)

Country Link
US (1) US6132721A (da)
EP (1) EP0814834B2 (da)
JP (1) JPH11501310A (da)
AT (1) ATE196255T1 (da)
AU (1) AU710626B2 (da)
BR (1) BR9607659A (da)
CA (1) CA2215483C (da)
DE (1) DE69610295T3 (da)
DK (1) DK0814834T4 (da)
GR (1) GR3034970T3 (da)
PL (1) PL322143A1 (da)
WO (1) WO1996027389A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720585D0 (en) * 1997-09-26 1997-11-26 Smithkline Beecham Biolog Vaccine
FR2773156B1 (fr) * 1997-12-26 2000-03-31 Biovacs Inc Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
FR2781158B1 (fr) * 1998-07-15 2002-12-13 Vacs Internat Nouvelles proteines modifiees immunogenes non immunosuppressives, leur procede de preparation et leurs applications
FR2792206B1 (fr) * 1999-04-13 2006-08-04 Centre Nat Rech Scient Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1
US20050226890A1 (en) * 1999-08-12 2005-10-13 Cohen David I Tat-based vaccine compositions and methods of making and using same
ATE465754T1 (de) * 1999-08-12 2010-05-15 Inist Inc Nicht-immunsuppresives hiv tat-protein
US20050244434A1 (en) * 1999-08-12 2005-11-03 Cohen David I Tat-based tolerogen compositions and methods of making and using same
US8323928B2 (en) 1999-08-12 2012-12-04 Pin Pharma, Inc. Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease
FR2802426B1 (fr) 1999-12-15 2004-04-02 Neovacs Utilisation de proteines immunogenes immunosuppressives et/ou angiogeniques rendues inactives, pour la production d'iga secretoires
WO2001054719A2 (en) * 2000-01-31 2001-08-02 Smithkline Beecham Biologicals S.A. Vaccine for the prophylactic or therapeutic immunization against hiv
NO314587B1 (no) * 2000-09-04 2003-04-14 Bionor Immuno As HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV
FR2828404B1 (fr) * 2001-08-10 2005-07-15 Neovacs Superimmunogene composite a usage vaccinal bifonctionnel pour le traitement des maladies associees a un desordre tissulaire stromal
WO2003054006A2 (en) * 2001-12-11 2003-07-03 Aventis Pasteur Mutated hiv tat
US7588764B2 (en) * 2002-03-01 2009-09-15 University Of Kentucky Research Foundation Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles
FR2844514B1 (fr) 2002-09-16 2007-10-19 Neovacs Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
US7927580B2 (en) * 2004-03-16 2011-04-19 Nanirx, Inc. Tat-based immunomodulatory compositions and methods of their discovery and use
NZ595060A (en) 2009-03-23 2013-05-31 Pin Pharma Inc Treatment of cancer with immunostimulatory hiv tat derivative polypeptides
JP2016533352A (ja) 2013-10-04 2016-10-27 ピーアイエヌ ファーマ インコーポレイテッド 免疫刺激性ＨＩＶ Ｔａｔ誘導体ポリペプチドによる癌の治療

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2227861B1 (da) † 1973-05-04 1976-07-02 Anvar
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
WO1989012461A1 (en) * 1988-06-16 1989-12-28 St. Louis University Antagonists of viral transactivating proteins
WO1991015224A1 (en) * 1990-03-30 1991-10-17 Smithkline Beecham Corporation Inhibition of disease associated with immunodeficiency virus infection
WO1991018454A1 (en) * 1990-05-18 1991-11-28 Centre National De La Recherche Scientifique Compositions capable of blocking cytotoxicity of viral regulatory proteins and neurotoxic symptoms associated with retroviral infection
JPH06508603A (ja) * 1991-02-14 1994-09-29 ラ　ホヤ　キャンサー　リサーチ　ファウンデーション ＨＩＶ　Ｔａｔタンパク質に対する新規インテグリン特異性
ATE245661T1 (de) * 1992-04-24 2003-08-15 Inst Human Genetics Biochem Natürliche menschliche igm antikörper
WO1993025235A1 (en) * 1992-06-09 1993-12-23 President And Fellows Of Harvard College Aids therapeutics based on hiv-2 vpx peptides
WO1994015634A1 (en) * 1992-12-30 1994-07-21 Matthias Rath Tat and rev oligopeptides in hiv treatment
FR2700169B1 (fr) * 1993-01-04 1995-03-24 Transgene Sa Nouveaux variants trans-dominants TAT du virus de l'immunodéficience humaine.
WO1995004546A1 (en) * 1993-08-06 1995-02-16 Kai Juhani Ernst Krohn Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses

Also Published As

Publication number Publication date
GR3034970T3 (en) 2001-02-28
AU5007196A (en) 1996-09-23
BR9607659A (pt) 1998-12-15
EP0814834B2 (fr) 2009-03-18
ATE196255T1 (de) 2000-09-15
CA2215483C (fr) 2012-01-03
EP0814834B1 (fr) 2000-09-13
AU710626B2 (en) 1999-09-23
PL322143A1 (en) 1998-01-05
US6132721A (en) 2000-10-17
CA2215483A1 (fr) 1996-09-12
DE69610295T2 (de) 2001-02-22
DE69610295T3 (de) 2009-10-08
DK0814834T4 (da) 2009-07-20
JPH11501310A (ja) 1999-02-02
EP0814834A1 (fr) 1998-01-07
WO1996027389A1 (fr) 1996-09-12
DE69610295D1 (de) 2000-10-19

Similar Documents

Publication Publication Date Title
DK0814834T3 (da) Immunogener, der er blottet for toksicitet, afledt af et retroviralt regulatorprotein, antistoffer, der er rettet mod disse
CY1106206T1 (el) Φαρμακευτικη συνθεση πepιεχουσα φενοφιβρατη και μεθοδος παρασκευης της
DE59504589D1 (de) Wäschenachbehandlungsmittel
GT200000103A (es) Trifluorbutenos nematocidas.
CY1105399T1 (el) Μεθοδος επιλεκτικης υποκαταστασεως των ταξανων
DK0788350T3 (da) Dannelse af små partikler
FI972093A0 (fi) Jäteveden käsittelymenetelmä ja -laitos
DK0671957T3 (da) Fremgangsmåde til behandling af et kirurgisk implanat af metal
FI971967A0 (fi) Dioksomorfoliinien käyttö sisäloisten torjuntaan, uusia dioksomorfiineja ja menetelmä niiden valmistamiseksi
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
CA2006816C (en) Improved glyphosate formulations
DK0790824T3 (da) 2,2-dichloralkancarboxylsyrer, fremgangsmåde til fremstilling deraf, lægemidler indeholdende disse og anvendelse af disse lægemidler til behandling af insulinresistens
PL292095A1 (en) Pesticides and method of obtaining them
PT778771E (pt) Emulsoes topicas de cetoconazole
ATE194995T1 (de) Polymerisationsfähige derivate von polyamiden
ES2176456T3 (es) Procedimiento de preparacion de un compuesto inhibidor del vih proteasa.
FI970703A0 (fi) Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine
DK0828753T3 (da) A1/Fe-behandling af en proteinopløsning efterfulgt af membranopkoncentrering
DE69830044D1 (de) Kugelförmige molekülgruppierung
DK0821593T3 (da) Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein
NO991419L (no) Farmas°ytiske sammensetninger omfattende S-alkylisotiouroniumderivater
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
NO179009C (no) Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol
DK0835309T3 (da) Vaccine imod infektiøse agenser, præparat til behandling og forebyggelse af HIV infektioner
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas